Dr. Truong is the Chair and Professor of Radiation Oncology at BUSM and Chief of Radiation Oncology at Boston Medical Center. She received her medical degree from the University of New South Wales, Sydney Australia and completed her residency in Radiation Oncology at New York University Medical Center, her last year as chief resident. She is board certified in Radiation Oncology by the American Board of Radiology. Her specialties include the treatment of head and neck, skin and central nervous system malignancies, as well as benign diseases, including Airway Amyloidosis. Dr. Truong serves on a number of national committees with leadership roles including the Scientific Committee of the American Society for Therapeutic Radiation Oncology (ASTRO), on the head and neck and skin examination committee of the American Board of Radiology (ABR), and currently serves in NRG Oncology (National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)) as the Quality of Life Head and Neck Liaison. She is the Quality of Life Co-Chair on several international head and neck cancer multicenter trials conducted by the NRG Oncology group. She contributes her radiation expertise to the National Cancer Institute’s Adult Oncology Treatment editorial board. She also leads the Cyberknife Radiosurgery program for head and neck malignancies and brain tumors. She is actively involved in promoting clinical research activities at Boston Medical Center, and was awarded funding as Principal Investigator for an American Cancer Society/Boston University Institutional Grant for the investigation of novel function imaging in head and neck cancer using CT perfusion Imaging in Patients with Head and Neck Cancer undergoing Conformal Radiotherapy. Dr. Truong has also contributed to several Boston Medical Center funded research efforts including two U.S. Army Medical Research and Material Command Office Center of Excellence Program Projects and was a project principal investigator of a department of defense funded study investigating the role of stereotactic body radiotherapy for recurrent head and neck cancer.
She has published over 100 peer-reviewed scientific articles, editorials, book chapters, and invited reviews.
In 2022, Dr Truong was awarded the Fellow of the American Society of Radiation Oncology for her contributions to the field of Radiation Oncology and service to ASTRO.
Since 2017 to 2023, she has been named Top Doctor in Castle Connolly’s America’s Top Doctors, Exceptional Women in Medicine, and Boston Magazine.
Boston University Chobanian & Avedisian School of Medicine
BU-BMC Cancer Center
Boston Medical Center
VA Boston Healthcare System
03/01/2014 - 02/28/2024 (PI)NRG Oncology Foundation, Inc. National Cancer Inst5UG1CA189867-10
Cancer Survivorship Clinic Navigation Program
04/01/2017 - 04/30/2019 (PI)Harvard Pilgrim Health Care / HPHC
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 99 results.
Qureshi MM, Lin Y, Moeller AR, Yan SX, Dyer MA, Suzuki K, Everett P, Litle V, Truong MT, Mak KS. Change in stage after neoadjuvant chemoradiation is associated with survival in patients with esophageal cancer. J Surg Oncol. 2023 Oct; 128(5):781-789.View Related Profiles. PMID: 37288789
Qureshi MM, Kam A, Suzuki K, Litle V, Tapan U, Balasubramaniyan R, Dyer MA, Truong MT, Mak KS. Association between hospital safety-net burden and receipt of trimodality therapy and survival for patients with esophageal cancer. Surgery. 2023 May; 173(5):1153-1161.View Related Profiles. PMID: 36774317
Oladeru OT, Lam CM, Qureshi MM, Hirsch AE, Mak KS, Dyer MA, Truong MT. Inequalities in Cancer Stage at Diagnosis Among Incarcerated Individuals Undergoing Radiation Therapy at a Large Safety-Net Hospital. Int J Radiat Oncol Biol Phys. 2023 May 01; 116(1):194-198.View Related Profiles. PMID: 36758643
Dang RR, Kim J, Qureshi MM, Fazeli SR, Zhao Q, Noonan VL, Sundararajan D, Salama A, Truong MT. Impact of depth of invasion on local recurrence in R0 resected node-negative oral tongue squamous cell carcinoma. Head Neck. 2023 Mar; 45(3):561-566.View Related Profiles. PMID: 36513522
Gillison ML, Ferris RL, Harris J, Colevas AD, Mell LK, Kong C, Jordan RC, Moore KL, Truong MT, Kirsch C, Chakravarti A, Blakaj DM, Clump DA, Ohr JP, Deeken JF, Gensheimer MF, Saba NF, Dorth JA, Rosenthal DI, Leidner RS, Kimple RJ, Machtay M, Curran WJ, Torres-Saavedra P, Le QT. Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504. Int J Radiat Oncol Biol Phys. 2023 Mar 15; 115(4):847-860. PMID: 36228746
Subramaniam RM, DeMora L, Yao M, Yom SS, Gillison M, Caudell JJ, Waldron J, Xia P, Chung CH, Truong MT, Echevarria M, Chan JW, Geiger JL, Mell L, Seaward S, Thorstad WL, Beitler JJ, Sultanem K, Blakaj D, Le QT. 18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002. J Nucl Med. 2023 Mar; 64(3):362-367. PMID: 36215572; PMCID: PMC10071810; DOI: 10.2967/jnumed.122.264424;
Lam CM, Qureshi MM, Patel PN, Park JJ, Dang RR, Rubin SJ, Salama AR, Truong MT. Oral cancer patients achieve comparable survival at high safety-net burden hospitals. Am J Otolaryngol. 2022 May-Jun; 43(3):103438.View Related Profiles. PMID: 35489110
Matthews BJ, Qureshi MM, Fiascone SJ, Nitschmann CC, Oladeru OT, Truong MT, Hirsch AE, Mak KS, Dyer MA. Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer. Gynecol Oncol. 2022 01; 164(1):27-33.View Related Profiles. PMID: 34785030; PMCID: PMC8711036; DOI: 10.1016/j.ygyno.2021.10.028;
Huang D, Qureshi MM, Sarfaty S, Truong MT, Dyer MA, Mak KS, Hirsch AE. Longitudinal Outcomes of Medical Student Research Mentorship: a 15-Year Analysis of the Radiation Oncology Mentorship Initiative. J Cancer Educ. 2023 Feb; 38(1):153-160.View Related Profiles. PMID: 34558038; DOI: 10.1007/s13187-021-02091-2;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
2017-2021 Castle Connolly’s America’s Top Doctors:
2017-2021 Boston Magazine Top Doctors:
2013 Annals of Nuclear Medicine Vol 26. 2012:
Bronze Prize, Best Three Papers
2011 RSNA annual scientific meeting 2011:
Certificate of Merit
2010 National Cancer Institute, Physician Data Query (PDQ) Editorial Board :
National Institutes of Health Merit Award
2010 RSNA annual scientific meeting 2010:
2008 RSNA annual scientific meeting 2008:
Certificate of Merit
2003 Radiological Society of North America:
Roentgen Resident Research Award
Available to Mentor as: (Review Mentor Role Definitions)
Students interested in oncology, radiation oncology, head and neck cancer, skin cancer, brain tumors, quality of life and outcomes research.
Students interested in gaining exposure to novel technology for cancer therapy including Stereotactic Radiosurgery, Cyberknife Radiosurgery for brain tumors, recurrent head and neck cancer, metastatic disease.
Research / Scholarly Mentor
Work / Life Integration Mentor